LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that it is scheduled to present at the Needham & Company Seventh Annual Biotechnology and Medical Technology Conference on Thursday, June 12, 2008. Michael G. Kauffman, M.D., Ph.D., chief executive officer of EPIX, is scheduled to discuss the company’s business strategy and corporate overview at 10:30 a.m. (ET) at The Palace Hotel in New York City.
